Valeant Hits Apotex With Patent Suit Over Colitis Drug
Toronto-based Apotex Inc. violated two of Valeant Pharmaceuticals International Inc.'s patents when it filed an application to make a generic version of Valeant's ulcerative colitis drug Giazo, according to a lawsuit...To view the full article, register now.
Already a subscriber? Click here to view full article